Garai Ildikó

1.

Csikos, C., Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T., Váradi, B., Sajtos, G. Z., Kapus, I., Szoboszlai, Z., Szikra, D. P., Tircsó, G., Krasznai, Z. T., Molnár, S., Garai, I., Trencsényi, G.: Enhanced Tumor-to-Background Contrast with [52Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer.
Pharmaceuticals. 19 (3), 1-16, (article identifier: 517), 2026.

doi DEA WoS

Journal metrics:

Q1 Drug Discovery (2024)

Q2 Molecular Medicine (2024)

Q1 Pharmaceutical Science (2024)

2.

Csikos, C., Varga, A., Molnár, S., Hascsi, Z., Bátyi, F., Garai, I., Krasznai, Z. T.: The role of PET/CT in preoperative decision-making for secondary cytoreduction in recurrent ovarian cancer.
BMC Cancer [Epub ahead of print], 2026.

doi DEA

Journal metrics:

Q2 Cancer Research (2024)

Q2 Genetics (2024)

Q2 Oncology (2024)

3.

Ogum, A., Barna, S., Szoboszlai, Z., Krizsán, Á. K., Renaud, J., Mitchell, T., Budai, Á., Ország, G., Csikos, C., Garai, I.: Coronary Flow Reserve Evaluation with a Novel Multi-pinhole Collimator on Triple-Na-I-detector SPECT/CT in Coronary Artery Disease: a Pilot Study.
EANM Innovation 1, S234, 2025.

doi DEA

4.

Pinczés, L. I., Tóthfalusi, D., Dobó, B., Barna, S., Farkas, B., Garai, I., Illés, Á., Miltényi, Z.: [delta]SUVmax adds prognostic value to early response assessment during the first-line treatment of classical Hodgkin lymphoma: a retrospective cohort study.
Cancer Imaging. 25 (1), 1-8, (article identifier: 80), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous) (2024)

Q2 Oncology (2024)

Q1 Radiological and Ultrasound Technology (2024)

Q1 Radiology, Nuclear Medicine and Imaging (2024)

5.

Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T., Szoboszlai, Z., Csikos, C., Váradi, B., Trencsényi, G., Tircsó, G., Garai, I.: HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab.
Pathol. Oncol. Res. 31, 1-12, (article identifier: 1611999), 2025.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research (2024)

Q2 Medicine (miscellaneous) (2024)

Q2 Oncology (2024)

Q2 Pathology and Forensic Medicine (2024)

6.

Einieh, M., Barna, S., Budai, Á., Ország, G., Csikos, C., Garai, I.: Integrating Whole-Body Bone SPECT and AI-Synthetic CT in the Evaluation of Non-Oncologic Disorders.
EANM Innovation. 1, S370-S371, 2025.

doi DEA

7.

Csikos, C., Varga, A., Hascsi, Z., Molnár, S., Krasznai, Z. T., Garai, I.: PET/CT-Guided Patient Selection for Secondary Cytoreduction in Recurrent Ovarian Cancer.
EANM Innovation. 1, S573, 2025.

doi DEA

8.

Ngo, M. T., Nagy, T., Szoboszlai, Z., Csikos, C., Dénes, N., Furka, A., Trencsényi, G., Garai, I.: The Relationship of Metabolic Activity and αvβ3 Receptor Expression in Aggressive Breast Cancer Subtypes Tumors: a Preliminary Report.
In Vivo. 39 (1), 160-171, 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2024)

Q3 Cancer Research (2024)

Q2 Medicine (miscellaneous) (2024)

Q3 Pharmacology (2024)

9.

Lengyel, M., Molnár, Á., Nagy, T., Jdeed, S., Garai, I., Horváth, Z., Uray, I. P.: Zymogen granule protein 16B (ZG16B) is a druggable epigenetic target to modulate the mammary extracellular matrix.
Cancer Sci. 116 (1), 81-94, 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research (2024)

D1 Medicine (miscellaneous) (2024)

Q1 Oncology (2024)

10.

Barna, S., Sira, L., Bhattoa, H. P., Tóth, L., Czine, Z., Szoboszlay, L., Nagy, E. B., Képes, Z., Garai, I., Bodor, M., Varga, J., Nagy, E. V.: [131I]6β-Iodomethyl-19-norcholesterol SPECT/CT for the Lateralization of Mineralocorticoid Overproduction in Primary Aldosteronism.
Diagnostics. 14 (17), 1-10, (article identifier: 1997), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Clinical Biochemistry

Q2 Internal Medicine

11.

Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T. M., Csikos, C., Váradi, B., Sajtos, G. Z., Kapus, I., Szoboszlai, Z., Szikra, D. P., Trencsényi, G., Tircsó, G., Garai, I.: [52 Mn]Mn-BPPA-Trastuzumab: A Promising HER2-Specific PET Radiotracer.
J. Med. Chem. 67 (10), 8261-8270, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Drug Discovery

Q1 Molecular Medicine

12.

Csikos, C., Barna, S., Kovács, Á., Czina, P., Budai, Á., Szolikova, M., Nagy, I. G., Husztik, B., Kiszler, G., Garai, I.: AI-Based Noise-Reduction Filter for Whole-Body Planar Bone Scintigraphy Reliably Improves Low-Count Images.
Diagnostics. 14 (23), 1-11, (article identifier: 2686), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Clinical Biochemistry

Q2 Internal Medicine

13.

Barna, S., Szolikova, M., Csikos, C., Török, J., Husztik, B., Varga, J., Kovács, Á., Garai, I.: Artificial Intelligence Based CT-free Attenuation Correction in Adolescent and Young Adult Mandibular Condylar Hyperplasia Patients.
Eur. J. Nucl. Med. Mol. Imaging. 51 (Suppl.), S778-S779, 2024.

doi DEA

14.

Esze, R., Barna, S., Fülöp, P., Kempler, P., Mikó, M., Páll, D., Paragh, G., Somodi, S., Emri, M., Képes, Z., Garai, I., Káplár, M.: C-peptide: an essential ally in microvascular complications of type 2 diabetes mellitus and obesity.
Diabetol Metab Syndr. 16 (1), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

Q1 Internal Medicine

15.

Esze, R., Balkay, L., Barna, S., Egeresi, L., Emri, M., Páll, D., Paragh, G., Rajnai, L., Somodi, S., Képes, Z., Garai, I., Káplár, M.: Impact of Fat Distribution and Metabolic Diseases on Cerebral Microcirculation: a Multimodal Study on Type 2 Diabetic and Obese Patients.
J Clin Med. 13 (10), 1-14, (article identifier: 2099), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

16.

Pham, A., Garai, I., Kovács, Á., Dér, Á., Szántó, E., Hascsi, Z., Bátyi, F., Berényi, E., Pham, T. M.: Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and Radiotherapy Planning in Head and Neck Squamous Carcinoma: a Retrospective Study of 46 Patients.
Med. Sci. Monitor. 30, 1-7, (article identifier: 942122), 2024.

doi DEA Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

17.

Káplár, M., Esze, R., Rajnai, L., Képes, Z., Balkay, L., Somodi, S., Paragh, G., Katkó, M., Emri, M., Garai, I., Fülöp, P.: Impact of liver fat content on serum levels of plasminogen activator inhibitor-1, fibroblast growth factor 21 and cerebral microcirculation in type 2 diabetes and obesity.

DEA

18.

Kallos-Balogh, P., Vas, N. F., Tóth, Z., Szakáll, S., Szabó, P., Garai, I., Képes, Z., Forgács, A., Egeresi, L., Dahlbom, M., Balkay, L.: Multicentric study on the reproducibility and robustness of PET-based radiomics features with a realistic activity painting phantom.
PLoS One. 19 (10), 1-24, (article identifier: 0309540), 2024.

doi DEA Scopus

Journal metrics:

Q1 Multidisciplinary

19.

Csikos, C., Czina, P., Molnár, S., Kovács, A. R., Garai, I., Krasznai, Z. T.: Predicting Complete Cytoreduction with Preoperative [18F]FDG PET/CT in Patients with Ovarian Cancer: a Systematic Review and Meta-Analysis.
Diagnostics. 14 (16), 1-14, (article identifier: 1740), 2024.

doi DEA Scopus

Journal metrics:

Q2 Clinical Biochemistry

Q2 Internal Medicine

20.

Csikos, C., Barna, S., Kovács, Á., Budai, Á., Szolikova, M., Nagy, I. G., Husztik, B., Kiszler, G., Garai, I.: Validation of an AI-Based Noise Reduction Filter on Bone Scan Images.
Eur. J. Nucl. Med. Mol. Imaging. 51 (Suppl.), S787, 2024.

doi DEA WoS

21.

Egeresi, L., Székely, A., Kallos-Balogh, P., Trón, L., Garai, I., Balkay, L.: Effect of Single-Slice CT Segmentation Methods on Fat Volume and Body Shape Estimation.
Acta Polytech. Hung. 20 (8), 89-109, 2023.

doi DEA Scopus

Journal metrics:

Q2 Engineering (miscellaneous)

Q2 Multidisciplinary

22.

Illés, Á., Garai, I., Miltényi, Z.: Hodgkin-lymphomás betegek kezelésével szerzett tapasztalataink.
Orv. hetil. 164 (11), 403-410, 2023.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

23.

Képes, Z., Mikó, M., Kukuts, K., Esze, R., Barna, S., Somodi, S., Káplár, M., Varga, J., Garai, I.: Imaging with [99mTc]HMPAO - a novel perspective: investigation of [99mTc] HMPAO leg muscle uptake in metabolic diseases.
Acta Radiol. 64 (1), 187-194, 2023.

doi DEA WoS Scopus

Journal metrics:

Q3 Medicine (miscellaneous)

Q3 Radiological and Ultrasound Technology

Q3 Radiology, Nuclear Medicine and Imaging

24.

Kálmán-Szabó, I., Képes, Z., Fekete, A., Vágner, A., Nagy, G., Szűcs, D., Gyuricza, B., Arató, V. Z., Varga, J., Kárpáti, L., Garai, I., Mándity, I. M., Bruchertseifer, F., Elek, J., Szikra, D. P., Trencsényi, G.: In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model.
J. Pharm. Biomed. Anal. 229, 1-9, (article identifier: 115374), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Clinical Biochemistry

Q2 Drug Discovery

Q2 Pharmaceutical Science

Q2 Spectroscopy

25.

Csikos, C., Vágner, A., Nagy, G., Kálmán-Szabó, I., Péli-Szabó, J., Ngo, M. T., Szoboszlai, Z., Szikra, D. P., Krasznai, Z. T., Trencsényi, G., Garai, I.: In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model.
Diagnostics. 13 (2), 236-, 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Clinical Biochemistry

Garai Ildikó

Publication list